medigraphic.com

2021, Number 4

<< Back Next >>

Rev Mex Anest 2021; 44 (4)

Anesthetic management for irreversible electroporation in the pediatric patient

Moreno-Ravelo IA, Sánchez-Acosta P, Sarmiento-Argüello LA

Language: Spanish
References: 17
Page: 277-281
PDF size: 211.06 Kb.


ABSTRACT

Introduction: Irreversible electroporation (IRE) is a technique known since 1972 incorporated into the oncological field in 2005 as a tumor ablation technique based on short high-voltage electrical pulses used to introduce chemical elements by diffusion, alter the cellular genetic structure, fuse a cell with other (reversible) or cause death (irreversible). These electric shocks carry an associated risk of cardiac arrhythmias, severe muscle contractions and seizures. Maintain an adequate anesthetic plane, optimal analgesia, deep neuromuscular relaxation and an electrocardiogram synchronized to the electrical pulses are the main objectives of anesthetic management. Objective: Describe the anesthetic implications of IRE in the pediatric patient. Material and methods: Narrative review based on a search for articles related to IRE in the most important databases, where the main source of information is case reports and non-systematic reviews of the literature, both in the area of anesthesiology and pain as well as engineering, vascular and cardiovascular interventional radiology, and surgery. Results: A total of 17 bibliographic references were found and reviewed. Conclusion: The anesthesia for IRE in the pediatric patient should guarantee an adequate anesthetic plane ideally with endotracheal intubation, optimal analgesia, deep relaxation and control of cardiac arrhythmias with electrocardiogram synchronization.


REFERENCES

  1. Villaverde J. Instrumentos para electroporación reversible e irreversible, con simulaciones de electroporación con el programa Quick-Field. Uruguay: Núcleo de Ingeniería Biomédica Universidad de la Republica; 2011. pp. 1-7.

  2. Deipolyi AR, Golberg A, Yarmush ML, Arellano RS, Oklu R. Electroporación irreversible: evolución de una técnica de laboratorio en oncología de intervención. Radiología de Intervención de Diagnóstico. 2014;20:147-154.

  3. Flor-Robledo M, Solís-Muñoz P, Sanjuán-Álvarez M, Abadal-Villayandre JM, Asensio-Merino F. Electroporación percutánea irreversible de un tumor renal: manejo anestésico. Rev Esp Anestesiol Reanim. 2016;63:419-422. http://dx.doi.org/10.1016/j.redar.2015.11.011

  4. Nielsen K, Scheffer HJ, Vieveen JM, van Tilborg AA, Meijer S, van Kuijk C, et al. Anaesthetic management during open and percutaneous irreversible electroporation. Br J Anaesth. 2014;113:985-992. doi: 10.1093/bja/aeu256.

  5. Pakhomova ON, Gregory BW, Khorokhorina VA, Bowman AM, Xiao S, Pakhomov AG. Electroporation-induced electrosensitization. PLoS One. 2011;6:e17100. doi: 10.1371/journal.pone.0017100.

  6. Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in "out of operating theater" anesthesia. Anesth Analg. 2010;110:1305-1309. doi: 10.1213/ANE.0b013e3181d27b30.

  7. Heller R, Davalos RV. Special collection on electroporation-based therapies: a selection of papers from the second world congress on electroporation. Technol Cancer Res Treat. 2019;18:1533033819852966. doi: 10.1177/1533033819852966.

  8. Thomson KR, Kavnoudias H, Neal RE 2nd. Introduction to irreversible electroporation--principles and techniques. Tech Vasc Interv Radiol. 2015;18(3):128-1234. doi: 10.1053/j.tvir.2015.06.002.

  9. Martin RC, Schwartz E, Adams J, Farah I, Derhake BM. Intra-operative anesthesia management in patients undergoing surgical irreversible electroporation of the pancreas, liver, kidney, and retroperitoneal tumors. Anesth Pain Med. 2015;5:e22786. doi: 10.5812/aapm.22786.

  10. Narayanan G. Irreversible electroporation. Semin Intervent Radiol. 2015;32:349-355. doi: 10.1055/s-0035-1564706.

  11. Thomson KR, Cheung W, Ellis SJ, Federman D, Kavnoudias H, Loader-Oliver D, et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol. 2011;22:611-621. doi: 10.1016/j.jvir.2010.12.014.

  12. Li W, Fan Q, Ji Z, Qiu X, Li Z. The effects of irreversible electroporation (IRE) on nerves. PLoS One. 2011;6:e18831. doi: 10.1371/journal.pone.0018831.

  13. Deodhar A, Dickfeld T, Single GW, Hamilton WC Jr, Thornton RH, Sofocleous CT, et al. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. AJR Am J Roentgenol. 2011;196:W330-W335. doi: 10.2214/AJR.10.4490.

  14. Kambakamba P, Bonvini JM, Glenck M, Castrezana López L, Pfammatter T, Clavien PA, et al. Intraoperative adverse events during irreversible electroporation-a call for caution. Am J Surg. 2016;212:715-721. doi: 10.1016/j.amjsurg.2016.07.001.

  15. Neal RE 2nd, Smith RL, Kavnoudias H, Rosenfeldt F, Ou R, Mclean CA, et al. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage. Cardiovasc Intervent Radiol. 2013;36:1638-1645. doi: 10.1007/s00270-013-0704-1.

  16. Satava R. Electroporation. Anesth Analg. 2010;110:1264. doi: 10.1213/ANE.0b013e3181d8cb74.

  17. Vieveen JM, Bouwman RA. Anesthetic management during irreversible electroporation procedures. In: Meijerink M, Scheffer H, Narayanan G (eds.). Irreversible electroporation in clinical practice. Springer, Cham. 2018. https://doi.org/10.1007/978-3-319-55113-5_6




2020     |     www.medigraphic.com